tirzepatide versus semaglutide weight loss vs Semaglutide: A Comprehensive Comparison for Semaglutide vs Tirzepatide results

Of the eight donors who were on incretin therapy, seven had been taking sitagliptin, sold in pill form as Januvia and marketed by Merck, and one had been on exenatide, sold as Byetta by Bristol-Myers Squibb

References: Fedoreyeva, L

The SUSTAIN-6 cardiovascular outcomes trial (which included thousands of type 2 diabetes patients taking semaglutide) showed that GLP-1 therapy actually reduced major adverse cardiovascular events by 26% compared to placebo

Chronic use of NAD + boosters is not without risks, as previously shown for cardiovascular events in in a large retrospective epidemiological study 15,30

Kitajima H, Hirota M, Iwai T, Hamajima K, Ozawa R, Hayashi Y, Yajima Y, Iida M, Koizumi T, Kioi M, Mitsudo K, Ogawa T